LCN2 and chronic kidney disease: Furthermore, it provides additional evidence to support evaluating adiponectin along with other plasma proteins such as apolipoprotein A-IV, fibroblast growth factor 23, neutrophil gelatinase-associated lipocalin, and the natriuretic peptides as a discriminatory biomarker of CKD progression [12].